Veltri L - Search Results

1

Pre-existing cardiovascular disease increases risk of atrial arrhythmia and mortality in cancer patients treated with Ibrutinib.

Avalon JC, Fuqua J, Miller T, Deskins S, Wakefield C, King A, Inderbitzin-Brooks S, Bianco C, Veltri L, Fang W, Craig M, Kanate A, Ross K, Malla M, Patel B. Avalon JC, et al. Among authors: veltri l. Cardiooncology. 2021 Nov 19;7(1):38. doi: 10.1186/s40959-021-00125-8. Cardiooncology. 2021. PMID: 34798905 Free PMC article.

2

Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin.

Veltri L, Regier M, Cumpston A, Leadmon S, Tse W, Craig M, Hamadani M. Veltri L, et al. Bone Marrow Res. 2013;2013:414959. doi: 10.1155/2013/414959. Epub 2013 Apr 17. Bone Marrow Res. 2013. PMID: 23691325 Free PMC article.

3

Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients.

Truong Q, Veltri L, Kanate AS, Hu Y, Craig M, Hamadani M, Cumpston A. Truong Q, et al. Among authors: veltri l. Ann Hematol. 2014 Apr;93(4):677-82. doi: 10.1007/s00277-013-1913-z. Epub 2013 Oct 6. Ann Hematol. 2014. PMID: 24097085

4

Hematopoietic progenitor cell mobilization with "just-in-time" plerixafor approach is a cost-effective alternative to routine plerixafor use.

Veltri L, Cumpston A, Shillingburg A, Wen S, Luo J, Leadmon S, Watkins K, Craig M, Hamadani M, Kanate AS. Veltri L, et al. Cytotherapy. 2015 Dec;17(12):1785-92. doi: 10.1016/j.jcyt.2015.09.002. Epub 2015 Oct 21. Cytotherapy. 2015. PMID: 26475754 Free PMC article.

5

Hematopoietic Progenitor Cell Mobilization with Ifosfamide, Carboplatin, and Etoposide Chemotherapy versus Plerixafor-Based Strategies in Patients with Hodgkin and Non-Hodgkin Lymphoma.

Dhakal B, Veltri LW, Fenske TS, Eastwood D, Craig MD, Cumpston A, Shillingburg A, Esselman J, Watkins K, Pasquini MC, D'Souza A, Hari P, Kanate AS, Hamadani M. Dhakal B, et al. Biol Blood Marrow Transplant. 2016 Oct;22(10):1773-1780. doi: 10.1016/j.bbmt.2016.06.016. Epub 2016 Jun 21. Biol Blood Marrow Transplant. 2016. PMID: 27345140 Free article.

6

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL).

Shah N, Rauenzahn S, Veltri L, Wen S, Craig M, Hamadani M, Kanate AS, Cumpston A. Shah N, et al. Among authors: veltri l. Bone Marrow Transplant. 2017 Feb;52(2):321-322. doi: 10.1038/bmt.2016.275. Epub 2016 Nov 28. Bone Marrow Transplant. 2017. PMID: 27892948 Clinical Trial. No abstract available.

7

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Anders B, Veltri L, Kanate AS, Shillingburg A, Shah N, Craig M, Cumpston A. Anders B, et al. Among authors: veltri l. Adv Hematol. 2017;2017:6464972. doi: 10.1155/2017/6464972. Epub 2017 May 14. Adv Hematol. 2017. PMID: 28588617 Free PMC article.

8

Patterns of Relapse After Salvage Autologous Stem Cell Transplant for Hodgkin's Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peri-Transplant Radiation Therapy.

Farris JC, Ritter A, Craig MD, Shah N, Veltri L, Kanate AS, Ross K, Vargo JA. Farris JC, et al. Among authors: veltri l. Pract Radiat Oncol. 2019 May;9(3):e290-e297. doi: 10.1016/j.prro.2018.12.006. Epub 2018 Dec 21. Pract Radiat Oncol. 2019. PMID: 30579808 Free PMC article.

9

Prospective assessment of Clostridioides (formerly Clostridium) difficile colonization and acquisition in hematopoietic stem cell transplant patients.

Austin K, Sweet M, Likar E, LaSala PR, Murray A, Wen S, Ross KG, Kanate AS, Veltri L, Matuga R, Cumpston A. Austin K, et al. Among authors: veltri l. Transpl Infect Dis. 2020 Dec;22(6):e13438. doi: 10.1111/tid.13438. Epub 2020 Aug 16. Transpl Infect Dis. 2020. PMID: 32767807 Free PMC article.

10

Toxicity assessment of concurrent gabapentin/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipients.

Angus J, Cumpston A, Veltri L, Ross KG, Wen S, Dillaman M. Angus J, et al. Among authors: veltri l. Support Care Cancer. 2021 Dec;29(12):7925-7930. doi: 10.1007/s00520-021-06385-5. Epub 2021 Jun 30. Support Care Cancer. 2021. PMID: 34191128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters